Itinerary: |
9:20 a.m. | Introduction by Zaneta Nikolovska-Coleska, Ph.D. Assistant Professor of Pathology Molecular & Cellular Pathology Program Director |
9:30 a.m. | Jon Pollock, B.S. Doctoral Candidate, Molecular & Cellular Pathology Mentors: Tomasz Cierpicki, Ph.D. and Jolanta Grembecka, Ph.D. Targeting menin-MLL-LEDGF complex with small molecules |
9:45 a.m. | Andrew Muntean, Ph.D. Assistant Professor of Pathology Cooperative mechanisms of leukemogenesis |
10:10 a.m. | Amy Han, M.S. Doctoral Candidate, Molecular & Cellular Pathology Mentor: Evan Keller, D.V.M., Ph.D. Identifying genes that regulate bladder cancer progression and invasion |
10:25 a.m. | David Lombard, M.D., Ph.D. Assistant Professor of Pathology Modulation of mitochondrial metabolism as an anti-cancer strategy |
10:50 a.m. | Break |
11:00 a.m. | Talha Anwar, B.S. Doctoral Candidate, Molecular & Cellular Pathology & Medical Scientist Training Program Mentor: Celina Kleer, M.D. Non-canonical functions of EZH2 in triple-negative breast cancers |
11:15 a.m. | Career panel *Jennifer Lippincott-Schwartz, Ph.D. - National Institutes of Health *Neali Lucas, Ph.D. - Food and Drug Administration *Charlie Taylor, Ph.D. - Pfizer *Ed Pagani, Ph.D. - U of M Office of Technology Transfer *David Lombard, M.D., Ph.D. - Assistant Professor, U of M Department of Pathology |
12:15 p.m. | Poster session and lunch |
1:30 p.m. | Keynote presentation – Navigating the cellular landscape with new optical probes, imaging strategies and technical innovationsJennifer Lippincott-Schwartz, Ph.D. Distinguished NIH Investigator Chief, Section on Organelle Biology Cell Biology and Metabolism Branch National Institute of Child Health and Human Development National Institutes of Health |
2:30 p.m. | Rebekah Martin, B.S. Doctoral Candidate, Molecular & Cellular Pathology Mentor: Michael Bachman, M.D., Ph.D. Identification of disease-associated genes in Klebsiella pneumoniae clinical isolates |
2:45 p.m. | Scott Tomlins, M.D., Ph.D. Assistant Professor of Pathology Next generation sequencing and 'n of 1': maximizing discovery from extraordinary patients |
3:10 p.m. | Break |
3:20 p.m. | Anuska Andjelkovic-Zochowska, M.D., Ph.D. Associate Professor of Pathology CCM3 in modulation of brain endothelial barrier integrity |
3:45 p.m. | Associate Professor of Pathology Ethics lecture Right to try? Should patients have access to Phase I pharmaceutical drugs at the end of life? |
4:10 p.m. | Awards presentation and concluding remarks |
| |